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ABSTRACT 
PROTEIN ENGINEERING OF COTA LACCASE 




Spore display offers advantages over more commonly utilized microbe cell-surface 
display systems. For instance, protein-folding problems associated with the expressed 
recombinant polypeptide crossing membranes are avoided. Hence, a different region of 
protein space can be explored that previously was not accessible. In addition, spores 
tolerate many physical/chemical extremes. The aim is to improve pH stability using spore 
display. The maximum activity of CotA is between pH 4 and 5 for the substrate ABTS 
(ABTS = diammonium 2, 2’–azino-bis(3-ethylbenzothiazoline-6-sulfonate)). However, 
the activity dramatically decreases at pH 4. The activity is not significantly altered at pH 
5. CotA is used as a model to prove that enzymes could be improved for pH resistance by 
using Bacillus subtilis spore display. First, CotA is evolved for increased half-life (t1/2) at 
pH 4. Next, a double mutant is constructed. This variant combines the amino acid 
substitutions from the improved t1/2 variant (E498G) and organic solvent tolerant mutant 
(T480A). The t1/2 and kinetic parameters are evaluated for the double mutant. 
Consequently, T480A/E498G-CotA is constructed and the t1/2 is 62.1 times greater than 
wt-CotA. Finally, T480A/E498G-CotA yields 5.3-fold more product than does wt-CotA 
after recycling the biocatalyst seven times over 42 h. Also, the mutant and wild-type are 
overexpressed in E. coli and purified. The enzymes immobilized in the spore coat are 
compared with the purified free protein. The t1/2 and catalytic efficiency follow the same 
ii
trends for spore or E. coli expressed wt-CotA and E498G-CotA, although the kinetic 
parameters are different. 
 In a previous investigation, a laccase (CotA), which is found on the spore coat of 
Bacillus subtilis, was engineered by directed evolution for improved activity in organic 
solvents. A CotA variant was identified with a Thr480Ala (T480A-CotA) amino acid 
substitution after only one round of evolution. The screen was performed at 60 % DMSO 
and it was 2.38-fold more active than the wild-type CotA (wt-CotA) with substrate ABTS. 
T480A-CotA was more active from a range of 0 – 70 % DMSO. In addition, the variant 
was more active in ethanol, methanol and acetonitrile. In this study, the catalysis of 
T480A-CotA and wt-CotA in the spore coat is determined with natural phenolic 
compounds, such as (+)-catechin, (-)-epicatechin and sinapic acid in aqueous-organic 
media. In general, the catalytic efficiency (Vmax/Km (A/OD580)/mM) of T480A-CotA is 
higher than wt-CotA for all the substrates. Then, the Vmax for T480A-CotA is greater than 
the wt-CotA in all organic solvents used in this study. The Vmax for T480A-CotA is up to 
3.4-fold, 7.9-fold and 6.4-fold greater than wt-CotA for substrate (+)-catechin, (-)-
epicatechin and sinapic acid, respectively. In addition, the catalyst can be easily removed 
from the reaction solution and reused. This allows for simpler recovery of the product 
from the enzyme. This investigation indicates that enzymes expressed on the spore coat 
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1.1 Evolution in Nature 
Evolution is the process by which organisms have descended from ancient ancestors. 
Time is not the main factor in evolution, but it is genetic inheritance [1]. In Darwin’s 
theory, all organisms share common ancestors [2]. Species change over time and space. 
Species living today are different from those in the past. This evolutionary change can be 
gradual and slow (Figure 1.1) [3].  
 
Figure 1.1  The evolutionary tree of life. Natural biological evolution is modification 
through genetic inheritance that passing on from parents to offspring. 




The primary mechanism of evolutionary change is natural selection. Charles 
Darwin introduced this concept in 1859 [4]. Variation exists within all populations of 
organisms and occurs partly because random mutations that take place in the genome of 
an individual organism. These mutations can be passed on from parent to offspring, 
therefore, such changes are heritable [5]. The struggle for resources will favor individuals 
with some variations over others from one generation to the next, and thereby change the 
frequency of traits within the population (Figure 1.2) [6]. For example, there may have a 
population of red beetles in ancient times. A mutation occurred in the DNA which caused 
the parents with genes for red coloration to have offspring with a gene for green 
coloration. This species lives on the tree; therefore, red beetles are easier for birds to 
identify and eat. Green beetles are a little more likely to survive to produce offspring. 
They pass their genes for green coloration on to their offspring because they blend into 





Figure 1.2  Evolution of red beetles. Evolution in nature happens over time based on 
differential survival of offspring. 
 
Evolution can also occur on the single molecule level, such as proteins. For 
example, myoglobin is an oxygen-binding protein found in the muscle tissue in almost all 
mammals. Myoglobin from human and whale contain 153 and 154 amino acids, 
respectively. There are 25 amino acid differences by comparing the sequences of both 
myoglobins (Figure 1.3) [7]. Thus, the proteins had a common ancestor and the number 
of amino acid substitutions in two related proteins is roughly proportional to the 
evolutionary time. These proteins have evolved in the context of the organism in order to 




Figure 1.3  Myoglobin evolution. Evolution can also occur on the single molecule level 
such as proteins. 
 
1.2 Directed Evolution 
Enzymes are potentially catalysts and can be used in industrial processes. They can be 
used as “green” catalyst because they operate at room temperature and aqueous solutions. 
Furthermore, they have high substrate specificity and can produce chiral products with 
high enantiomeric excess [8]. However, these advantages can also be shortcomings when 
used in industrial conditions, because they have evolved for millions of years and adopted 
specific properties. In industry, extreme conditions are used such as high salt 
concentration, temperature, and organic solvents. These conditions often inactive 
enzymes [9]. As a result, an efficient method must be used to engineer and optimize the 
enzymes.  
The two extremes of protein engineering are rational design and evolutionary 
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(irrational) methods. Rational design requires in-depth knowledge of the protein structure, 
and its catalytic mechanism [10]. Amino acid substitutions are guided by the structure of 
the protein. However, it is still extremely difficult to predict the effect of an individual 
amino acid mutation even with a known structure. Therefore, this method is not always 
reliable for protein engineering and optimization. On the other hand, evolutionary 
methods do not require a structure or details of the mechanism of the desired activity [11]. 
The only requirement is the gene of interest. This method uncovers amino acid 
substitutions than one can never predict. For example, amino acid substitutions that 
improved catalytic activity can be far from the active site [12]. As a result, evolutionary 
strategies, also known as directed or laboratory evolution, have become the methods of 
choice. It opens a way to overcome some of the barriers to implement proteins for 
application in industry, biotechnology, and pharmaceuticals [13].  
Directed evolution is a protein engineering method that mimics natural evolution. 
The main goal of this engineering strategy is to obtain proteins with improved or 
optimized properties, for example resistance to unusual pH, temperature, organic solvent, 
etc. Furthermore, amino acid substitutions uncovered that optimize a protein can be used 
to study structure/function relationships [14].  
Directed evolution is an iterative process and there are four general steps: (1) 
diversification: generate gene library of the target protein (2) expression of protein library 
(3) screen the library under a specific condition for desired functions and (4) amplify the 




Figure 1.4  An illustration of directed evolution. Directed evolution is a protein 
engineering method that mimics natural evolutions.  
 
The size of DNA library needs to be addressed. The mutation rate needs to be 
controlled to make the library size manageable because libraries may have to be 
exhaustedly screened to discover a winner. It is physically impossible to screen extremely 
large libraries. The number of variants V of a protein of amino acid length L that differ by 





For example, a protein of L = 300, the number of variants with a mutation number H = 1 












of variants V is 1.610
7
. Finally, the number of variants (V) with a mutation number H = 
3 is 310
10 
(Table 1.1). It becomes physically impossible to effectively screen library 
sizes with a mutation rate greater than 2. As a result, the mutation rate should be 
approximately 2 per gene.  
 
Table 1.1  Number of Amino Acid Changes versus Number of Variants. 











Note: The number of variants of a 300 amino acid long protein. 
 
Many powerful technologies were developed to create a sizable library and 
generally can be divided into three categories: 1) saturation mutagenesis, which is a 
method to simultaneously introduce the other 19 amino acid at a specific site [16];  
2) random mutagenesis, which mimics asexual reproduction [17]; 3) DNA recombination, 
also known as DNA shuffling, which mimics sexual reproduction [18].  
Saturation mutagenesis is a technique that generate all possible (or as close to as 
possible) mutations at a specific site or a narrow region of a gene. It involves the 
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randomization of one codon of a gene using synthetic oligonucleotides possessing a 
randomized codon flanked by wild-type sequences. Several codons may also be 
randomized, simultaneously, though this results in large libraries. This technology is 
limited because it requires knowledge of functional important regions of the enzyme, and 
relies heavily on structural insights for site specific targeting in proteins.  
Random mutagenesis and DNA recombination are more commonly evolutionary 
strategies used in the laboratory [19]. Random mutagenesis mimics asexual reproduction 
and introduces random mutations in the gene of interest by a thermal stable DNA 
polymerase [20]. The reaction condition of the polymerase chain reaction (PCR), which 
amplifies DNA, is altered in order to introduce random mutations in the gene [21]. This is 
called error prone PCR (ep-PCR). Ep-PCR has several steps (Figure 1.5): (1) The gene is 
selected; (2) the target gene is amplified; (3) the PCR products are inserted into a carrier 




Figure 1.5  Scheme of random mutagenesis. Random mutagenesis mimics asexual 
reproduction and is commonly done by epPCR. 
 
The second type is recombination of genes that mimics sexual reproduction: DNA 
shuffling [22,23]. Generally, DNA shuffling can be divided into several steps (Figure 1.6). 
(1) The gene fragments are first created by DNAse digestion. Each fragment may contain 
mutations. The different colors along the genes in Figure 1.6 represent different mutations. 
For example, yellow may denote blond hair, and blue may represent blue eyes. (2) The 
full-length of DNA is generated PCR. (3) After amplification, the target DNA is inserted 




Figure 1.6  Scheme for DNA shuffling. DNA shuffling was developed to mimic sexual 
reproduction. 
 
1.3 Protein Display 
The principle of protein display technologies is the ability to physically link phenotypes 
of polypeptides displayed in a certain system to their corresponding genotype, which was 
first shown for phage display [24]. This connection must remain intact for a successful 
evolution experiment. These technologies could be divided into two major categories, in 
vivo and in vitro. In vitro includes phage and cell surface display, while in vivo consists of 




Figure 1.7  Scheme of available display technologies. All display platforms are based 
on the ability to physically link the polypeptide produced by a library clone to its 
corresponding genotype. This allows one to recover the DNA encoding the clone selected 
based on the desired polypeptide phenotype, such as binding to the target [25]. 
 
1.3.1 In vitro Protein Display 
The major potential advantage of in vitro protein display over in vivo methods is the size 
of the libraries that can be displayed and therefore the diversity subject to selection, 
because in cell-free assays there is no transformation step and no limit for library 
diversity [26]. However, in vitro methods have limitations. For example, mRNA display 
is not suitable for displaying membrane-bound proteins due to the difficulty in expressing 
such proteins using in vitro translation systems [27]. Also, screening conditions that may 
break the genotype/phenotype connection should not be applied. These technologies were 
12 
 
usually used to screen for specific high-affinity target-binding molecules including 
peptides, antibody fragments, and whole functional proteins presented by various 
scaffolds [28,29]. 
The connection between the genotype and phenotype is achieved by different 
strategies in these in vitro technologies (Figure 1.7). In ribosome display, linkage between 
the gene and the encoded polypeptide is achieved by stabilization of complexes between 
the ribosome, mRNA and the encoded polypeptide upon termination of elongation with a 
permissive marker, such as chloramphenicol or low temperature [30]. In mRNA display, 
linkage between the gene and the encoded polypeptide is achieved by a puromycin 
molecule covalently bonding the mRNA 3’-end and the translated polypeptide upon the 
ribosome stalling at the junction of mRNA and an engineered single-stranded DNA linker 
[28]. In covalent DNA display, linkage between the gene and the encoded polypeptide is 
achieved by covalent bond that forms between the DNA-binding protein P2A (produced 
as a fusion with polypeptide) with the DNA encoding the fusion [28].  
 
1.3.2 In vivo Protein Display 
Generally the screening can be performed under in vivo conditions [31]. This means 
proteins translated from DNA libraries can be transported to the microorganism. 
“Traditional” methods such as phage display [32], bacterial display [33,34] and yeast 
display [35,36] are suitable when the evolved protein is to be used in living organisms 




Figure 1.8  “Traditional” methods of protein display. Protein can be displayed with (A) 
phage, (B) yeast or (C) Escherichia coli (E. coli). 
 
In general, there are two screening strategies. The first one is expressing protein 
libraries inside the host, for example, in the cytoplasm of E. coli (Figure 1.9A). The other 
way is first expressing protein libraries inside the host, and then transporting the protein 
to the surface to be displayed outside the host cells (Figure 1.9B). This strategy is called 
cell surface display. The protein displayed on the cell surface is often fused to a carrier 
protein. The carrier protein is usually a natural occurring protein found on the surface or 





Figure 1.9  Two strategies of screening. (A) Proteins are expressed inside the host. Red 
structure represents proteins, grey structure represents DNA, and in blue is the cell 
surface; (B) Protein displayed outside the host cell. Green circle represents carrier 
proteins. 
 
Displaying proteins libraries on the cell surface has advantages over expressing 
libraries inside the cells. If the protein is displayed inside, then the cells must be lysed to 
gain access to the protein for the assay (Figure 1.10). Therefore, the connection between 
genotype and phenotype will be lost (Figure 1.11). In other words, the improved protein 
and the gene that codes for it is separated and must be retrieved from another plate 
(Figure 1.10). In addition, the assay is hindered because of multiply liquid handling steps. 
For example, the cell lysates require centrifugation in order to pellet the cell debris and 
the supernatant may be pipetted into another reaction vessel for the assay (Figure 1.10). 
Finally, the assay solution is complicated furthermore by the soluble contents of the cell, 




Figure 1.10  Screening protein libraries in the cell. 1) Library is transformed into cells. 
2) Single colonies are picked into microtiter plate and grown. 3) A duplicate plate is made 
and the original plate is stored to retrieve the gene of the improved protein variant. This 
gene is used a parent for the next rounds of evolution. 
 
Cell surface display may overcome issues discussed above. First, the 
genotype/phenotype connection remains intact. Next, substrates or protein targets are 
freely accessible. Furthermore, liquid handling is minimal. In addition, there is more 
control of the assay conditions because it is not complicated by addition of the soluble 






Figure 1.11  Genotype/phenotype connection for proteins expressed inside the cell. Cell 
lysis is necessary to gain access to the protein. As a result, the genotype-phenotype 
connection will be lost. 
 
Many strategies are developed for directed evolution by using cell surface display. 
Figure 1.12 shows steps of an example of evolving a protein to bind a specific target:  
(1) Gene libraries are transformed into cells. (2) The library is expressed on the cell 
surface and each cell contains a unique member of the gene library. (3) The library is 
screened for binding a target. (4) The proteins that bind nonspecifically are eliminated by 
a wash step. (5) The improved protein is released from the target. (6) The cells are 




Figure 1.12  An example of directed evolution by cell surface display. A library is 
screened by using affinity binding assay. 
 
Traditional cell surface display methods are powerful and many proteins were 
evolved for improved properties or functions [37]. This technology has transformed 
protein discovery in industry and academia. For example, E. coli is considered an 
attractive host because of the availability of various genetic tools and mutant strains and 
the high transformation efficiency for screening of a large peptide or protein library after 
surface display [38]. Screening displayed proteins with extreme properties has many 
advantages in designing pharmaceuticals and industrial catalyst. Although protein display 




Cell viability is a major issue. For example, industrial reaction conditions may 
require elevated temperatures or organic solvents to dissolve hydrophobic substrates.  
However, screening with harsh assay conditions will lyse the cells and the 
genotype/phenotype connection will be lost (Figure 1.12, step 3; Figure 1.13). 
Furthermore, screening under extreme conditions or toxic substrates, the cell will not 
remain viable. As a result, the cells cannot be cultured and the gene cannot be isolated 
(Figure 1.12, step 5 & 6).  
 
Figure 1.13  Problems in traditional cell surface protein display. The connection of 
genotype and phenotype will be gone if the cell is lysed under harsh condition. 
 
Also, there are protein folding issues. In E. coli for instance, disulfide bonds 
cannot properly form because the proteins are expressed in the cytoplasm, which is a 
reducing environment [39]. Also, the target proteins must travel through several 
membranes to reach cell surface. First, the protein travels through the inner membrane, 
and then passes across the peptidoglycan layer, and finally the protein travels to the outer 
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membrane (Figure 1.14). This causes misfolded and nonfunctional proteins. Taken 
together, these technologies limit the numbers of proteins that can be displayed [40,41].  
 
Figure 1.14  Cell membrane structure of E. coli. Proteines are first expressed in 
cytoplasm. They may misfold when travelling across membranes to the surface. 
 
1.3.3 E. coli Cell Surface Display 
Among Gram negative bacteria, E. coli has been extensively investigated in cell surface 
engineering. It is an attractive host for cell surface display because of the availability of 
various genetic tools and mutant strains and the high transformation efficiency for 
screening of a large peptide or protein library. To display heterologous proteins onto the 
surface of E. coli, different strategies were used. These include the insertion of the target 
sequences into the surface exposed outer membrane proteins; insertion of target 
sequences into a protein forming part of a cell surface structure such as a flagellum; or 
20 
 
the fusion of target sequences to the N-terminus of lipoproteins (Figure 1.15).  
The major problem is the target proteins need to cross two bacterial membranes to 
reach the extracellular surface. This may cause protein misfolding and disfunction. Also, 
the fragility of outer membrane caused by the display of proteins can be a problem. In 
addition, this method cannot be used to evolve proteins with extreme properties, which is 
due to viability issues as mentioned above. 
 
 
Figure 1.15  Different strategies to display passenger proteins (green circles) on the 




1.3.4 Yeast Cell Surface Display 
Yeast surface display involves the expression of protein of interest on the yeast cell wall 
by using N-terminal fusion or C-terminal fusion and it can be used for post-translational 
modification found in eukaryotic organisms (Figure 1.16) [35]. Using -galactosidase as 
a target protein, it was demonstrated that a number of cell wall proteins (Cwp1p, Cwp2p, 
Ag1p, Tip1p, Flo1p, Sed1p, YCR89w, and Tir1) could be used as N-terminal fusion 
[42]. For C-terminal fusion, the most widely used anchor is Aga2. The cell wall protein 
a-agglutinin consists of two subunits, Aga1p and Aga2p. Aga1p is incorporated into the 
cell wall, whereas Aga2p fused with a target protein is conjugated to Aga1p via a 
disulfide bond. 
Glycosylated proteins have been successfully displayed on yeast. However, 
differential glycosylation may interfere with the function of the displayed protein [43]. A 





because of low transformation efficiency. In addition, this method also suffers from 




Figure 1.16  Schematic illustration of a yeast cell surface display. 
    
1.4 Spore Display 
Spores may overcome the problems associated with traditional protein display. A brief 
overview of sporulation needs to be discussed for the gram-positive organism Bacillus 
subtilis. Bacterial spores are formed in response to starvation. The best studied 
spore-forming bacteria is B. subtilis, which is found to have no safety concerns for 
labotory use. Sporulation of B. subtilis (Figure 1.17) proceeds through a well-defined 
series of morphological and biosynthetic steps: (1) an asymmetric division of the 
sporulating cell creates a sporangium composed of two compartments: the mother cell 
and the forespore. The mother cell nurtures the forespore and the proteins that make up 
the coat are synthesized. (2) The mother cell engulfs the forespore as the spore coat is 
formed. Coat assembly begins just after the initiation of engulfment and continues 
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Figure 1.17  B. subtilis sporulation process. 
  
Spores are the most resistant form of life on earth and remain viable under 
extreme chemical and physical conditions and they do not lyse. As a result, proteins can 
be evolved to possess extreme properties. For example, displayed proteins can be evolved 
to remain active in organic solvents [44]. Screening under these conditions would lyse the 
cell in traditional protein display, which would separate the gene from the improved 
protein (Figure 1.18A). In short, spore display maintains the genotype/phenotype 
connection intact (Figure 1.18B). In addition, protein folding problems associated with 
the target protein traveling through cell membranes is eliminated, which is due to the 
natural sporulation process [45]. Furthermore, the mother cell contains ATP-dependent 




Figure 1.18  Illustration of traditional display and spore display. (A) The connection of 
genotype and phenotype is lost under harsh conditions in traditional display methods. (B) 
The connection of genotype and phenotype remain intact under harsh conditions in spore 
display. 
 
Spore displayed proteins is convenient and has economic advantages in industrial 
application. For example, enzymes are immobilized on the inert surface of spore coat and 
become more stable. Next, spores can be easily removed from the reaction mixture to 
ease in product purification. 
 
1.4.1 Composition of the B. subtilis Endospore 
The B. subtilis spores are encased in a well protecitve coat consisting of an inner coat and 
outer coat that make the spores can withstand extremes of heat, desiccation, and 
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chemicals (Figure 1.19). The coat outside the spores are composed of >70 different 
proteins (Figure 1.20). The layer beneath the inner coat is called cortex, separated from 
the coat by a outer membrane. The cortex is composed predominantly of peptidoglycan 
with a structure similar to that of peptidoglycan in growing cells. The cortex is essential 
for the attainment and maintenance of the dehydrated state of the spore core, for spore 
mineralization and for dormancy [45]. The central part of the spore is the core, separated 
from the cortex by a inner membrane. It contains one copy of the bacterial chromosome 
and plasmid copies if present in the vegetative cell. The DNA molecules in the core are 
complexed with small acid-soluble proteins (SASPs), making up as much as 20 % of the 
total spore protein [46]. 
 





1.4.2 Protein Displayed by B. subtilis Spores 
As descirbed above, the proteins on the spore coat are synthesized inside the sporulating 
mother cells and deposited on the spore surface as prespores emerge (Figure 1.17). Thus, 
proteins can be displayed on the spore surface by fusing with coat proteins (Figure 1.20). 
Up to now, B. subtilis spore display has been used for a range of biotechnological 
applications, such as vaccine development [38,47-49] and whole-cell biocatalysts [50]. 
Our group first demonstrated that the spore display system could be used for directed 
evolution [51]. 
The spore-display system is based on the construction of gene fusions between 
heterologous DNA and a B. subtilis gene coding for a spore coat protein that located on 
the spore surface. The outer surface proteins CotG, CotB, and CotC were demonstrated to 
be able to display enzymes and heterologous antigens. All three proteins are tyrosine-rich 
and present as multimers within the spore coat [52]. CotG has a central region formed by 
nine tandem repeats of a lysine-, serine-, and arginine-rich motif [53]. CotB is a 46-kDa 
polypeptide which is posttranslationally converted into a form of about 66 kDa [54]. 
CotC forms multimeric species with itself [55].  
Until now, CotG has been used to display -galactosidase (-Gal) [50]. 
-Galactosidase is a very large protein (116 kDa per monomer), and active only as a 
tetramer and known to be toxic to the host cell. The successful display of this protein 
functionally on spore coat demonstrated the advantage of spore display. Also, solvent 
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stability of surface expressed -galactosidase in organic solvents was significantly 
increased as compared to the free form of soluble -galactosidase. CotB and CotC was 
used to display the amyQ-encoded -amylase and GFPuv [56]. Enzymes displayed on 
spores behave like immobilized enzymes, showing correct function, and enhanced 
stability toward heat and solvents. They can be used as spore-immobilized biocatalysts. 
Two heterologous antigens, tetanus toxin fragment C (TTFC) from Clostridium tetani, 
and a heat-labile toxin of E. coli (LTB), are displayed on the spore surface with CotC, and 
could be used to create a combination vaccine. 
Highly expressed proteins may also be adsorbed to the spore surface via 
hydrophobic or electrostatic protein–protein interactions, other than fusing to a carrier 
protein on spore coat [57]. This method broadened the application of spore display for 
protein engineering, because the fusion protein hinders the correct conformation, and 
some proteins are not amenable to N-terminal or C-terminal fusion. However, the 
absorbed enzyme may diffuse from the surface. This would complicate product isolation 
in a reaction solution because the enzyme is in mixture. 
There are several ways to improve spore display. First, the majority of spore 
display examples often rely on stable integration of an expression construct into the 
chromosome of B. subtilis. However, this approach presents several limitations, such as 
low expression level and complex operation. Utilizing a high copy number E. coli–B. 
subtilis shuttle vector can help to overcome these problems [56,58]. Also, B. subtilis cells 
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produce a variety of intra- and extracellular proteases. Target proteins anchored on the 
spore surface are first exposed to intracellular proteases and, after lysis of the mother 
cells, to extracellular proteases. To prevent the degradation of target proteins, the 
eight-fold protease-deficient strain B. subtilis was used [59]. Finally, the spore surface 
could be re-engineered to enhance molecular display. The spores are covered with coat 
and spore crust proteins, therefore, evolved coat proteins may further improve the 
efficiency of display. 
 





Laccases are members of multicopper oxidase family enzymes. It was first found in the 
sap of the Japanese lacquer tree Rhus vernicifera [61]. Hence, the name of the enzyme is 
laccase. They have diverse physiological roles such as lignin synthesis [62], lignin 
degradation [63], pathogenesis [64] and morphogenesis [65]. They catalyze many 
substrates. In laccase-catalyzed one-electron oxidation processes, four molecules of 
substrate are oxidised in order to reduce a dioxygen molecule to two waters molecules. 
Substrate oxidation occurs at the mononuclear T1 centre and then the electrons are 
shuttled, along a T1 coordinating cysteine, to the two histidines that are coordinating the 
T3 coppers of the trinuclear centre, where reduction of dioxygen occurs (Figure 1.21). 
Laccases have applications in the textile industry, paper bleaching, chemical synthesis, 
biofuel cells, and bioremediation [66]. 
 




CotA, a laccase, is an endospore coat protein in B. subtilis (Figure 1.22). The 
physiological role of CotA in B. subtilis has not been determined. Spores have a 
characteristic brown color. If CotA is knocked out of the genome, the spores lose this 
color. The color protects the spores from UV light and peroxide [67]. In addition, it 
assists with melanin biosynthesis and cross-link coat protein structure components. 
 
Figure 1.22  Ribbon diagram of the ABTS–CotA complex. ABTS is shown as colored 
spheres. The model of ABTS-CotA complex was generated by UCSF Chimera (Resource 
for Biocomputing, Visualization, and Informatics (RBVI), UCSF). 
Source: http://www.rcsb.org/pdb/explore/explore.do?structureId=3ZDW (accessed on April 18, 2017) 
 
Spore display was first applied to directed evolution in our laboratory and 
increasing substrate specificity was the goal. A library of cotA were expressed on spore 
coat and screened for activity toward ABTS [diammonium 
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2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonate)] over SGZ 
(4-hydroxy-3,5-dimethoxy-benzaldehyde azine) [51]. A library of approximately 3000 
clones was screened in one round of evolution. A threonine to leucine substitution at 
position 260 was uncovered and it was 120-fold more specific for ABTS (Figure 1.23). 
 
Figure 1.23  Ribbon diagram of Thr260Leu-CotA. The model of Thr260Leu-CotA was 
generated by UCSF Chimera (Resource for Biocomputing, Visualization, and Informatics 
(RBVI), UCSF). 
 
We wanted to take advantage of the inert properties of the spore coat and evolve a 
protein with extreme properties. CotA was evolved for improved activity under 
conditions of high organic solvent concentrations [44]. A cotA library was expressed on 
spore coat and approximately 3000 clones were screened at 60 % dimethyl sulfoxide 
(DMSO) in one round of evolution. A threonine to alanine amino acid substitution at 
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position 480 variant (Figure 1.24) was identified that was 2.38 fold more active than the 
wild-type CotA. In addition, Thr480Ala-CotA was more active with varying 
concentrations of DMSO ranging from 0 – 70 %. The mutant was also found to be more 
active compared to wild-type CotA in different concentrations of methanol, ethanol and 
acetonitrile.  
 
Figure 1.24  Ribbon diagram of Thr480Ala-CotA. The model of Thr480Ala-CotA was 










DIRECTED EVOLUTION OF COTA LACCASE FOR ACIDIC PH 
STABILITY BY USING BACILLUS SUBTILIS SPORE DISPLAY 
 
Bacillus subtilis spores can be used for protein display to engineer and optimize protein 
properties. This method overcomes viability and protein folding concerns associated with 
traditional protein display methods. Spores remain viable under extreme conditions and 
the genotype/phenotype connection remains intact. In addition, the natural sporulation 
process eliminates protein-folding concerns that are coupled to the target protein 
travelling through cell membranes. Furthermore, ATP-dependent chaparones are present 
to assist in protein-folding. In general, proteins that are immobilized have advantages in 
biocatalysis. For example, the protein can be easily removed from the reaction and it is 
more stable.  
We recently showed that spores could be utilized for directed evolution. The 
laccase CotA, which is a B. subtilis spore coat protein, was the target. A library of cotA 
genes was expressed on the spore coat, and it was evolved for improved substrate 
specificity [51]. Next, spores are able to remain viable under extreme conditions, and 
CotA was evolved for improved activity in high concentrations of organic solvents [44]. 
E. coli or yeast protein display methods are not compatible with screening with high 
concentrations of organic solvent because the cell would lyse and the connection between 
the gene and the improved protein is lost. The next goal was to optimize CotA as a whole 
cell biocatalyst immobilized in an inert matrix of the spore coat for improved pH stability 
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using spore display. 
In general, pH has an effect on enzyme activity. Each enzyme has its own 
optimum pH to undergo catalysis. It is because pH can change the state of ionization of 
acidic or basic amino acid, therefore change the structure of the enzyme. Enzymes will be 
inactive because the 3-dimensional structure will be altered (Figure 2.1) [68]. Also, pH 
may change ionization state of substrates. As a result, the substrate may not bind to the 
enzyme. In industry, extreme low or high pH may be applied. Most enzymes will be 
inactive under these conditions. In this case, enzymes that can resist extreme pH are 
desired. For example, α-amylase was engineered to improve the stability at low pH to 
meet the starch industry environment [69]. Corn starch is converted to fructose/glucose 
syrup by α-amylase, and this process also includes steam injection to reduce the viscosity.  
The reaction occurs at pH 6, but a low pH is desired to prevent unwanted byproducts. 
Acid resistant enzymes have applications in degradation of polymeric or oligomeric 
carbon sources, biofuel production, textile industry, and fruit juice production [70].  
 




The maximum activity of the laccase CotA with the substrate ABTS is between 
pH 4 and 5. However, it was found that the activity dramatically decreases at pH 4. The 
activity is not significantly altered at pH 5. We used CotA as a model to prove that 
enzymes could be improved for pH resistance by using Bacillus subtilis spore display. 
First, CotA was evolved for increased half-life (t1/2) at pH 4. Next, a double mutant was 
constructed. This variant combined the amino acid substitutions from the improved t1/2 
variant and organic solvent tolerant mutant. The t1/2 and kinetic parameters were 
evaluated for the double mutant. 
 
2.1 Materials 
Chemicals used were analytical grade or higher. 
2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), citric acid, disodium 
phosphate, copper(II) chloride were purchased from Sigma Aldrich (St.Louis, MO). 
Ampicillin, spectinomycin, chloramphenicol was purchased from Fisher Scientific 
(Pittsburgh, PA). DNA purifications kits were purchased from Qiagen (Valencia, CA). 
Primers were purchased from Fisher Scientific (Pittsburgh, PA). Enzymes were purchased 







2.1.1 Library Construction 
The plasmid, pDG1730CotA, was previously constructed, which contains the CotA gene 
under control of its natural promoter. Libraries were constructed with help from Dr. Han 
Jia (Figure 2.2). Random mutagenesis libraries were created by error prone PCR (ep-PCR) 
using GeneMorph II Random Mutagenesis (Agilent Technologies, La Jolla, CA.). A 
typical 50 μL GeneMorph reaction contained pDG1730CotA (3000 μg,), primers 
BacsubF (125 ng; 5’-GCGCGCAAGCTTGTGTCCATGGCGTT-3’) and Psg1729 (125 
ng; 5’GCGCGGATCCTTATTTATGGGGATCA-3’), dNTP mix (40 nmol, 10 nm each), 
and Mutazyme II DNA polymerase (2.5 U) and 5 μL buffer. The PCR program consisted 
of 30 cycles at 95 °C for 30 s, 56.3 °C for 30 s and 72 °C for 4 m. 
Libraries were also made using taq polymerase. A typical 100 μL ep-PCR reaction 
contained pDG1730CotA (100 ng), dGTP (20 nmol), dATP (20 nmol), dCTP (100 nmol), 
dTTP (100 nmol), primers BacsubF and Psg1729 (500 ng each), MgCl2 (0.7 mM), 
Platinum Taq DNA Polymerase (5 U, Invitrogen, Grand Island, NY) and reaction buffer 
(10 μL). The PCR program consisted of 30 cycles at 95 °C for 30 s, 56.3 °C for 30 s and 




Figure 2.2  CotA was amplified with error prone PCR and transformed into E.coli. 
 
For each library, the PCR product was digested with HindIII and BamHI and was 
cloned into the same sites in the plasmid pDG1730. The resulting plasmids were 
transformed into E.coli DH5α and plated on LB plates containing ampicillin (100 μg/mL). 
The transformants were collected together and the plasmids were isolated. The library 
was integrated into the amyE locus into B. subtilis strain 1S101 (Ohio State University, 




Figure 2.3  CotA library was transformed into Bacillus subtilis and displayed on cell 
surface. 
 
This transformation was achieved by double cross-over recombination. This strain 
is a cotA knockout strain (Figure 2.4). 
 






2.2.1 Spore Screening for Acid-stability 
Expression of the library in 96-deep-well plates was previously described [71]. After 
expression, the plates were centrifuged and the media discarded. The spores were 
resuspended in 200 μL spore control solution [sterile water containing CuCl2 (0.25 mM)] 
and incubated at room temperature for 30 min. Next, two assay plates were constructed 
for screening. One plate had 40 μL spore control solution in each well as control plate, 
and the other had 40 μL spore control solution with 100 μL citrate phosphate buffer (100 
mM, pH 4) containing CuCl2 (0.25 mM) as assay plate. Both plates were at room 
temperature for two hours. After incubation, 100 μL citrate phosphate buffer (100 mM, 
pH 4) containing CuCl2 (0.25 mM) was added into each well of the control plate. ABTS 
(1.0 mM, pH 4) was added into each well for both plates to initiate the reaction, and 
allowed to react for 20 minutes. The plates were centrifuged and the supernatants were 





). Next, the ratio of AbspH 4 at 420 nm : Abscontrol at 420 nm was determined. Positive 
clones were selected that showed at least 1.5 the mean value of wild-type ratio of AbspH 4 
at 420 nm : Abscontrol at 420 nm. A rescreen was carried out to eliminate false positives. The 
assay was similar to above, but multiple colonies from a single clone were picked into a 




2.2.2 Acid Inactivation 
Large-scale sporulation was initiated by media exhaustion, and the spores were purified 
using published procedures [72]. The half-life of acid inactivation (t1/2) of spores was 
determined. Purified spores were incubated in aqueous CuCl2 (0.25 mM) for 1 hour at 37 
o
C. Then, the spores were centrifuged and resuspended in citrate-phosphate buffer (100 
mM, pH 4, 0.25 mM CuCl2) and incubate in 37 
o
C. The resulting solution had an OD580 
between 0.1 – 0.3. A 200 μL reaction was initiated by adding ABTS (10 mM) into the 
spore solution. The measurements were performed every 3 to 10 minutes at 420 nm until 
the activity decreased to 20 % of the initial activity. The data was recorded in triplicate. 
 
2.2.3 Kinetics Measurements of CotA and CotA Variants 
All measurements were done in triplicate with at three different batches of purified spores. 
The kinetic parameters of spores were determined at 37 
o
C by using ABTS (1 – 8000 μM) 
in citrate phosphate buffer (100 mM, pH 4). The spores were first suspended in aqueous 
CuCl2 (0.25 mM) solution for 60 minutes. Then the reactions were initiated by adding 50 
μL spore solution into wells of each concentration of ABTS. The final OD580 of spores 
was between 0.2 – 0.3. The initial rates were acquired from the linear portion of the 
reaction curve. Kinetic parameters were obtained by curve fitting (SigmaPlot 12.0, Systat 





2.2.4 Product Yield of CotA and Its Variants 
CotA recycling was investigated and the total product yield was determined over 42-hour 
period. The spores were resuspended in aqueous CuCl2 (0.25 mM) solution for 60 
minutes at 37 °C. Next, the spores were centrifuged and the supernatant was discarded. 
The spores were resuspended in citrate phosphate buffer (100 mM, pH 4) at 37 °C with a 
final OD580 of 0.15. The spores were incubated for two hours and then the spores 
centrifuged and the supernatant was discarded. The reaction was initiated by 
resuspending the spore with 1 mL ABTS (20 mM) in citrate phosphate buffer (100 mM, 
pH 4) at 37 °C. The absorbance was taken at 420 nm after 15 minutes to determine the 
product yield. This cycle was repeated seven times over 42-hours. 
 
2.2.5 Cell Viability 
Purified spore were incubated in aqueous CuCl2 (0.25 mM) for one hour. Next, the spore 
solution was added to citrate phosphate buffer (100 mM, pH = 4, 0.25 mM CuCl2) and 
incubated for 4 hours. Then, the solutions were diluted and plated on LB plates 
containing spectinomycin (100 μg/ml) and chloramphenicol (5 μg/mL). 
 
2.2.6 Overproduction in Escherichia coli and Purificaiton of CotA and Its Variants 
A 5.0 mL of the overnight culture was used to inoculate LB media (1 L) containing 
ampicillin (100 μg/mL). The cells were shaken at 250 rpm at 37
o
C. The cells were then 
induced by adding arabinose (0.2 %) and CuCl2 (0.25 mM) when OD600 = 0.6. After 4 
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hours, the cells were harvested by centrifugation at 9,000 g and 4 
o
C and the cell pellets 
were stored at -20
o
C until purification.  
CotA was purified using two chromatographic steps. The cell pellets were 
resuspended in 20 ml Tris-HCl (20 mM, pH 7.6) buffer containing DNaseI (10 μg/mL), 
MgCl2 (5 mM), and protease inhibitors (CompleteTM, mini EDTA-free protease inhibitor 
mixture tables, Roche Molecular Biochemicals). Cells were disrupted by sonication (4 x 
30 sec; output power 20 watts; Sonicator, Sonic Dismembrator Model 100, Fisher 
Scientific). The lysate was centrifuged at 15,000 g and 4 
o
C for 20 minutes. The 
supernatant was filtered using 0.45 μm filter (Millex-HV, Millipore) and then diluted to 
50 mL with Tris-HCl buffer. The solution was loaded onto an ion exhange SP-Sepharose 
column (bed volume 25 mL) that was equilibrated with Tris-HCl (20 mM, pH 7.6). The 
sample was loaded and eluted using a two-step linear NaCl gradient (0 – 0.5 and 0.5 – 1 
M) in the same buffer. Fractions displaying laccase activity were pooled, concentrated by 
ultrafiltration with a cutoff of 30 kDa, and equilibrated to 20 mM Tris-HCl (pH 7.6).The 
sample was then loaded onto MonoS 5/50 column, and eluted using a two-step linear 
NaCl gradient (0 – 0.5 and 0.5 – 1 M). Fractions with laccase activity were pooled, 
desalted, and concentrated. A single band was shown by SDS-PAGE (12.5 %) at 100 kDa 






2.2.7 Acid Inactivation and Kinetics Measurement of Purified CotA 
0.5 µg purified enzyme was used for acid inactivation assay. Dilute the protein with 
aqueous CuCl2 (0.25 mM) and incubate at 37 
o
C for 30 min. Then, on a 96-well 
microplate, each well contains 100 µl citrate phosphate buffer (100 mM, pH 4, 0.25 mM 
CuCl2) with 0.5 µg treated protein and incubate under 37 
o
C. The reaction was initiated 
every 10 minutes by adding 10 µl ABTS (1 mM) into one well on the 96-well microplate. 
The initial rates were acquired from the linear portion of the reaction curve.  
Purified enzyme was diluted in aqueous CuCl2 (0.25 mM) and incubated at 37 
o
C 
for 30 min. The kinetic parameters were then determined at 37 
o
C by using ABTS (1 – 10 
mM) in citrate phosphate buffer (100 mM, pH 4, 0.25 mM CuCl2). The reactions were 
initiated by adding 0.5 µg enzyme. The initial rates were acquired from the linear portion 
of the reaction curve. Kinetic parameters were obtained by curve fitting. 
 
2.3 Results and Discussion 
Many strategies have been developed for directed evolution. They are either in vivo or in 
vitro. Taking advantage of the inert properties of spores, we demonstrate that proteins can 
be evolved under harsh condions by using a system based on spores of B. subtilis. In this 
system, the protein of interest is “preimmobilized” on the spore coat and screened as 
whole cell. Therefore, the connection between phenotype and genotype is intact. CotA is 
a laccase, which is a B. subtilis spore coat protein. The optimal enzymatic activity of 
CotA laccase was found at pH 4.0 – 5.0 for substrate ABTS oxidation. However, the 
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activity dramatically decreases at pH 4 (Figure 2.5). The activity is not significantly 
altered at pH 5. 
 
Figure 2.5  Optimal enzymatic activity was found at pH 4.0 – 5.0 for ABTS. However it 
also has the relatively lowest stability at pH 4.  
 
CotA laccase was evolved for higher stability at low pH = 4 by using B. subtilis 
spores. Liraries of CotA were first created by random mutagenesis wild-type B. subtilis as 
template. They were then inserted into vector pDG1730 and transformed into B. subilis 
genome with double crossover recombination. The B. subtilis strain had the endogenous 
cotA gene knocked out. Next, the B. subtilis cells were sporulated in 96-deep-well plates. 
A screen need to be validated to reduce the probability of selecting false positives. In 
order to validate the screen, only wild-type CotA is arrayed in the 96-deep well plates. A 
low coefficienct of variance (CV) in needed. There are many factors to obtain a low CV, 
such as incubation time and temperture, inductution time and temperture, shaker speed, 
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eliminate evaporation, etc…A suitable CV is approximately 20 %. Therefore, CotA 
activity with ABTS was measured before and after incubating the spores in citrate 
phspate buffer (100 mM, pH 4) for 60 min. The average of the coefficient of variance 
(CV) was 15.7 % for 3 microtiter plates (Figure 2.6).  
 
 
Figure 2.6  An example of one microtiter plate of coefficient of variance (CV). The 
clones were ranked from highest to lowest activity. CV is defined as the ratio of the 
standard deviation to the mean. 
 
Positive clones were selected that showed at least 1.5 the mean value of wild-type 
ratio of AbspH 4 at 420 nm : Abscontrol at 420 nm. A rescreen was carried out to eliminate false 
positives. The assay was similar to above, but multiple colonies from a single clone were 
picked into a column of a 96-deep well plate. A wild-type control column was also 
included. Approximately 3000 mutants were screened and a mutant, Y19, was identified 





Table 2.1  Kinetic Parameters and Half-life of Wild-type CotA and CotA Variants 
Mutation Vmax
[a]
 Km (μM) Vmax/Km t1/2
[b]
 
E29V 29.4 ± 1.4 67.2 ± 9.2 0.44 60.4 ± 3.7 
L343S 14.7 ± 0.5 58.2 ± 6.4 0.25 33.4 ± 2.3 
E498G 41.8 ± 3.7 857.6 ± 125.9 0.05 1264.1 ± 78.0 
E29V/L343S/E498G 18.5 ± 0.5 358.6 ± 29.4 0.05 302.6 ± 23.8 
T480A 120.6 ± 2.5 112.3 ± 6.9 1.07 56.1 ± 1.1 
T480A/E498G 45.5 ± 3.0 585.1 ± 76.4 0.08 3166 ± 431.1 
Wt-CotA 33.3 ± 1.1 58.8 ± 7.2 0.57 50.9 ± 1.8 
Kinetic parameter and half-life of inactivation at pH 4 for WT-CotA and CotA variants. [a] μM/min/OD580 
nm. [b] Half-life (minutes) at pH 4. 
 
The sequence of Y19 was determined from isolated genomic DNA and three 
amino acid substitutions [E29V (GAA to GTA), L343S (TTG to TCG), E498G (GAA to 
GGA)] were found (Appendix B). Val29 and Ser343 are on the surface, while Gly498 is 




Figure 2.7  Molecular model of ABTS-Y19. Molecular model of the ABTS-Y19 
complex was generated using Maestro software from Schrodinger (Schrodinger, Maestro 
v9.2, Portland, 2011). Copper, ABTS, and the amino acids are rendered as CPK models. 
 
The CotA variants that carry only one mutation were also constructed to 
determine the contribution the amino acid substitution had on pH stability and catalytic 
efficiency (Figure 2.8, Table 2.1, Figure 2.9). The t1/2 of E498G variant was 1213.2 
minutes longer than wt-CotA, which was 24.8 times greater. The E498G substitution is 
the only amino acid required for the increased t1/2 (vide infra). The The Vmax/Km for 
E498G was 8.8 % compared to wt-CotA. A lowering of Vmax/Km is not unusual because 
this property was not included in the pH stability screen (Table 2.1). The change in 
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Vmax/Km for the variant was mainly due to 14.6 fold increase in Km, which was partially 
compensated with a 1.3 fold increase in Vmax. 
 
 
Figure 2.8  The t1/2 at pH 4 of wt-CotA and CotA variants. The t1/2 is determined from 
first order kinetic of deactivation. Wt-CotA (closed circles), E29V (open circle), L343S 
(closed triangles), E498G (open triangle), and Y19 (closed square) residual activity at pH 














Figure 2.9  Kinetic parameters of wt-CotA and CotA variants on Bacillus subtilis spore 
coat. (A) Kinetic parameters of Y19 (E29V/L343S/E498G). Km = 358.6 ± 29.4µM; Vmax = 









Figure 2.9 (continued)  Kinetic parameters of wt-CotA and CotA variants on Bacillus 
subtilis spore coat. (C) Kinetic parameters of E29V. Km = 67.2 ± 9.2 µM; Vmax = 29.4 ± 
1.4 mM/min/OD580nm. (D) Kinetic parameters of L343S. Km = 58.2 ± 6.4 µM; Vmax = 14.7 







Figure 2.9 (continued)  Kinetic parameters of wt-CotA and CotA variants on Bacillus 
subtilis spore coat. (E) Kinetic parameters of wt-CotA. Km = 58.8 ± 7.2 µM; Vmax = 33.3 ± 
1.1 mM/min/OD580nm. 
 
In a previous investigation, Glu
498
 was mutated to aspartate, threonine and leucine, 
and it was suggested that these amino acid substitutions near His
497
 resulted in minor 
changes in substrate binding and electron transfer to the T1 site [73,74]. Substrate 
oxidation at the T1 site has been proposed to be the rate-limiting step in the reaction 
[75,76]. The mutagenesis investigations also proposed that Glu
498
 was necessary for 
proton assisted reductive cleavage of the O-O bond at the trinuclear copper center. The 
E498G variant does not have a side chain that can facilitate the cleavage. However, the 
amino acid substitution is also expected to alter substrate binding and electron transfer. 
Glycine is known to have greater conformational flexibility because the side chain is 
hydrogen. The mutation may have altered the position ABTS for efficient electron 
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transfer and the Vmax was increased. On the other hand, this was at a cost to substrate 
binding which resulted in a higher Km. In addition, the glycine substitution is adjacent to 
the His497, which coordinates to Cu
2+
 in the T1 site. Hence, the Cu
2+
 coordination 
geometry may also be affected such that metal binding has increased, and the protonation 
of the histidine ligands is hindered. Protonation of the histidine would result in release of 
Cu
2+
 from the T1 site and loss of enzymatic activity. The enzyme is imbedded in the 
spore coat and the structure of the mutant has not been solved. Hence, it is difficult to 
extract conclusions based on the structure of ABTS bound to CotA. The structure of the 
soluble CotA may not be identical to the enzyme that is embedded and restrained in the 
spore coat.  
Wt-CotA was evolved for increased activity in high concentrations of organic 
solvents previously [44]. An assay was performed at 60 % dimethyl sulfoxide (DMSO) 
and a variant was identified to be 2.4-fold more active after screening 3000 clones after 
one round of evolution. The clone was found to have a threonine to alanine amino 
substitution at position 480 (T480A-CotA). T480A-CotA was also more active with 
different concentrations of DMSO ranging from 0 to 70 %. The mutant was also found to 
be more active compared with the wild-type CotA in different concentrations of methanol, 
ethanol, and acetonitrile [44]. The amino acid substitution in T480A-CotA was introduced 
into the E498G-CotA to create T480A/E498G-CotA. The t1/2 for the T480A/E498G-CotA 
at pH 4 was found to be 3165.6 ± 431.1 minutes, which was 62.1-fold greater than 
wt-CotA (Table 2.1). When compared to wt-CotA, the Vmax for T480A/E498G-CotA was 
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slightly increased by 1.4-fold; whereas, the Km increased 10-fold. The Vmax in the double 
mutant was due to the T480A amino acid substitution and the E498G mutation was 
mainly responsible for the increase in Km (Table 2.1). The crystal structure has not been 
determined for T480A-CotA, E498G-CotA and T480A/E498G-CotA. As a result, it is 
difficult to conclude the effect that the T480A mutation has towards improved pH 
stability of T480A/E498G-CotA.  
The activity of wt-CotA, T480A-CotA, E498G-CotA and T480A/E498G-CotA 
was determined in different organic solvent (DMSO, methanol, ethanol and acetonitrile).  
The variants did not show greater activity than the wt-CotA (Figure 2.10). In short, the 
T480A/E498G-CotA and E498G-CotA have comparable similar kinetic properties, but 


























Figure 2.10  Vmax (M/min/OD580nm) of wt-CotA (light shaded bars), 
T480A/E498G-CotA (dark shaded bars) and E498G-CotA (white bars) in 0 – 70 % 
















Figure 2.10 (continued)  Vmax (M/min/OD580nm) of wt-CotA (light shaded bars), 
T480A/E498G-CotA (dark shaded bars) and E498G-CotA (white bars) in 0 – 70 % 




An important feature of a biocatalyst is that it can be reused for several cycles. 
E498G and T480A/E498G have a larger Km compared to the wt-CotA, which resulted in 
a lower Vmax/Km (Table 2.1). However, the variants had a higher product yield compared 
to the wt-CotA, which was due to the longer t1/2 (Table 2.1). The spores were recycled 7 
times over 42 h (Table 2.2, Figure 2.11). Wt-CotA, E498G-CotA and 
T480A/E498G-CotA had a total yield of 24.8, 92.9, and 131.3 mmole, respectively. 
E498G-CotA and T480A/E498G-CotA yielded 3.7- and 5.3-fold more product than the 
wt-CotA. This also demonstrates that the biocatalysts can be recycled. T480A/E498G 
was the most stable biocatalyst and retained 42 % of its activity after the 42 h period. 
Table 2.2  Product Yields of Wild-type CotA and CotA Variants 
Time (hour) Wt-CotA E498G T480A/E498G 
0 11.1 ± 0.1 20.2 ± 0.3 19.8 ± 0.2 
2 3.3 ± 0.5 19.6 ± 0.2 19.4 ± 0.2 
4 2.8 ± 0.6 15.4 ± 0.9 18.9 ± 0.9 
8 1.9 ± 0.7 12.4 ± 1.6 18.0 ± 1.6 
18 1.6 ± 0.2 9.1 ± 0.2 15.9 ± 0.2 
25 1.8 ± 0.4 7.6 ± 1.2 14.4 ± 1.2 
30 1.3 ± 0.2 5.3 ± 0.9 13.4 ± 0.9 
42 1.0 ± 0.3 3.3 ± 0.3 11.5 ± 0.3 
Total 24.8 92.9 131.3 
Product yield (mmole) of ABTS
+





Figure 2.11  Product yields of ABTS
+
 of wt-CotA and its variants over 42 h. The spores 
were recycled and measured for 7 cycles over 42 h. 
 
The surface amino acid substitutions, E29V and L343S variants, do not 
significantly contribute to the pH stability to Y19 (Table 2.1). E29V mutant has a slight 
decrease in Vmax/Km (0.77-fold) and a modest increase in t1/2 (1.2-fold) compared to 
wt-CotA. Next, the L343S mutant had a decreased Vmax/Km and a decrease in t1/2 
compared to wt-CotA of 0.44- and 0.66-fold, respectively. It appears that the E29V and 
L343V amino acid substitutions have a deleterious effect.  
The spore coat proteins were extracted and the amount of wt-CotA and the 
mutants were comparable as assessed by SDS-PAGE gels (Figure 2.12). The band 
intensity in lanes 4 – 8 were quantified using ImageJ (https://imagej.nih.gov/ij/). The 
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values for lane 4 – 8 were 7045, 6798, 7716, 7171, and 7012, respectively. The average 
of the intensities was 7151  344. The amount of protein present in the spore coat are 
similar between the samples. 
 
 
Figure 2.12  Extraction of spore coat proteins. Lane 1: Marker; Lane 2: CotA standard 
purified from E. coli; Lane 3: CotA knockout; Lane 4: Wildtype CotA; Lane 5: 
E29V-CotA; Lane 6: L343S-CotA Lane 7: E498G-CotA; Lane 8: T480A/E498G-CotA. 
Spores (A580 = 100) were resuspended in 50 µl of sodium dodecyl sulfate (SDS) loading 
dye (SDS (4 %), 2-mercaptoethanol (10 %), dithiothreitol (1 mM), Tris-HCl (0.125 M, 
pH 6.8), glycerol (10 %) bromophenol blue (0.05 %). The samples were heated at 100 
o
C 
for 10 minutes. Next, the samples were centrifuged, and 25 µl of the supernatant were 
resolved with 15 % SDS-PAGE gels. Gels were stained with Coomassie brilliant blue 
R-250 and destained.  
 
Cell viability was determined in citrate phosphate buffer (100 mM, pH 4). The 





Figure 2.13  Viability assay of spores in citrate phosphate buffer (100 mM, pH 4). 
 
Enzymes embedded in the spore coat may have different activity compared to the 
protein that is free in solution. Hence, wt-CotA and E498G-CotA was overproduced and 
purified from E. coli. However, T480A/E498G-CotA was expressed as inclusion bodies 
(Figure 2.14) and it could not be recovered. This is not unusual. In previous publication, 
wt-CotA was expressed in E. coli for molecular and biochemical characterization and 
only 10 % of the CotA was soluble and the rest were inclusion bodies [77]. Efforts were 
made to solublize and refold the protein were not successful. In our case, we see similar 
results. Wt-CotA and E498G-CotA have both a soluble and inclusion body fraction and 
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the these enzymes were purified. T480A/E498G-CotA expressed as an inclusion body 
and could not obtain enough soluble protein to purify and characterize. 
A 
 
Figure 2.14  SDS-PAGE analysis of CotA overproduction in E. coli. (A) Lane 1: 
Marker; Lane 2: CotA standard purified from E. coli; Lane 3: supernatant of a crude 
extract of an arabinose-induced E. coli culture of wt-CotA; Lane 4: insoluble fraction of a 
crude extract of an arabinose-induced E. coli culture of wt-CotA; Lane 5: supernatant of a 
crude extract of an arabinose-induced E. coli culture of E498G-CotA; Lane 6: insoluble 
fraction of a crude extract of an arabinose-induced E. coli culture of E498G-CotA; Lane 
7: supernatant of a crude extract of an arabinose-induced E. coli culture of 
T480A/E498G-CotA; Lane 8: insoluble fraction of a crude extract of an 
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Figure 2.14 (continued)  SDS-PAGE analysis of CotA overproduction in E. coli. (B) 
Lane 1: Marker; Lane 2: purified wt-CotA from E.coli without boiling; Lane 3: purified 
wt-CotA from E.coli boiled for 5 min; Lane 4: purified wt-CotA from E.coli boiled for 10 
min; Lane 5: purified E498G-CotA from E.coli without boiling; Lane 6: purified 
E498G-CotA from E.coli boiled for 5 min; Lane 7: purified E498G-CotA from E.coli 
boiled for 10 min. 
 
The t1/2 (Figure 2.15) and catalytic efficiency follow the same trends for spore or 
E. coli expressed wt-CotA and E498G-CotA, although the kinetic parameters (Table 2.3) 
are different (Figure 2.16). The catalytic efficiency of purified or spore expressed 
wt-CotA is greater than E498G-CotA. It is clear that the purified enzyme and spore 
displayed enzyme have different catalytic efficiencies. There are many complex 
interactions with the spore coat proteins.  
 
Table 2.3  Kinetics Parameters of Purified Wild-type CotA and E498G-CotA 
 Km (µM) Vmax (µM/s) Kcat (s
-1
) Kcat/Km 
Wildtype 156.3±23.7 0.512±0.03 23.2±1.3 0.15 





Figure 2.15  The t1/2 at pH 4 of wt-CotA and E498G-CotA. The t1/2 is determined from 
first order kinetic of deactivation. Wt-CotA (closed circles) and E498G-CotA (open circle) 
residual activity at pH 4 is plotted against time. The t1/2 of wt-CotA was determined as 11 
min. For E498G, there is a “stable period” around 60 min when the activity of the protein 
does not change relatively according to time. A half-life of inactivation of 274 min was 
determined; if the initial 60-min “stable period” is considered, a t1/2 of 334 min can be 


















































Figure 2.16  Kinetic parameters of purified wt-CotA and E498G-CotA from E.coli. A. 




B. Kinetics of 








In this study, a library of CotA laccase was constructed and transformed into Bacillus 
subtilis. An assay at acidic pH was then developed and a mutant was found with 
improved t1/2 in acidic pH than wildtype. Also, the viability of spores was proven to be 
intact in this condition. The spores were able to be recycled and the total amount of 
product formed after approximately 2 days was greater for the variants when compared to 

















OXIDATION OF PHENOLIC COMPOUNDS WITH COTA LACCASE AND ITS 
MUTANT ON BACILLUS SUBTILIS SPORE COAT IN ORGANIC MEDIA 
 
Enzymes are green and efficient catalysts because they operate at room temperature and 
aqueous solutions. Furthermore, they have high substrate specificity that can produce 
chiral products with high enantiomeric excess. Therefore, the application of enzymes in 
industry is continuously increasing. However, these desired characteristics may not be 
suited for industrial applications [78-80]. For example, enzymes may have low catalytic 
efficiency with non-natural substrates. Next, hydrophobic substrates are not soluble in 
aqueous solutions and an organic co-solvent must be added for the reaction to occur. In 
general, enzymes are not stable in organic solvents and they lose activity [81-83]. Protein 
structure is due to the balance of forming the hydrophobic core, Van der Waals forces, 
electrostatic interactions, and hydrogen bonding. Organic solvent disrupts the 
hydrophobic core and the protein will unfold. Furthermore, organic solvents can strip 
water from the protein surface, which is necessary for structure and function. Finally, the 
enzymatic activity will decrease in organic solvent due to thermodynamic reasons. In 
aqueous solution, the substrate is surrounded by water and oftentimes the active site is 
hydrophobic. It is energetically favorable for the substrate to be desolvated and partition 
into the hydrophobic active site. Hydrophobic substrates are thermodynamically 
stabilized in the organic solvent compared to water. 
 Enzyme immobilization has several advantages [84,85]. First, protein stability 
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can be increased. Next, they are more resistant to environment changes, which can 
enhance the lifetime in organic solvents. Furthermore, substrates are freely accessible to 
biocatalyst. Finally, the enzyme can be easily removed from reaction mixture for reuse 
[86]. Protein display on the surface of the microorganisms is one strategy to immobilize 
enzymes [87]. 
Traditional cell surface display systems, such as Escherichia coli and yeast, 
appear ideal; however, there are several issues [39]. Lysis may occur during the reaction 
and contents of the cells will enter into the solution. As a result, this will add additional 
contamination and separating the enzyme from the reaction solution may be required. 
Spores overcome these issues. Spores remain viable under extreme chemical and physical 
conditions [88,89]. As a result, enzymes displayed on its surface can tolerate extreme 
properties. They will not lyse and can be easily removed from the reaction solution. In 
addition, protein folding problems associated with the target protein crossing cell 
membranes is eliminated.  Furthermore, there is no need to overexpress, purify, and 
attach the protein to an inert surface. This is due to the natural sporulation process [90].  
In addition, the whole cell biocatalyst can be recycled and reused, which reduces the 
overall cost associated with product yield. 
Natural phenolic compounds have beneficial biological effects. They can act as 
antioxidants [91], antimutagens [92] and anticarcinogens [93]. For example, (+)-catechin 
(Figure 3.1A) and (-)-epicatechin (Figure 3.1B), are two phenolic isomers that can be 
found in green tea, and they are responsible for the potential health benefits [94]. 
67 
 
However, they affects the flavor and mouth-feel and these compounds can be removed by 
polymerization [95]. As a result, the sensory quality is enhanced [96]. Polycatechins can 
be utilized to prevent neurodegenerative and cardiovascular diseases [97,98]. Enzymes, 
such as laccase, have been used to polymerize phenolic compounds for a variety of 
applications [99,100] (Figure 3.2A). One limitation is that these polymers are insoluble 
and require organic co-solvents.  
 
           A                    B                         C 
Figure 3.1  Structure of phenolic substrates. (A) (+)-catechin; (B) (-)-epicatechin; and 
(C) sinapic acid. 
 
Next, rapeseed meal (RSM) is widely utilized to feed all classes of livestock. 
Sinapic acid (Figure 3.1C) and the choline ester of sinapic acid (sinapine) are the major 
phenolic compounds found in RSM [101,102]. These compounds or their derivatives 
lower the nutritional value of RSM. In addition, they render RSM to be bitter and 
astringent [103,104] . Biocatalysts can be used to eliminate these antinutrients [105]. The 








Figure 3.2  Oxidation of phenols by laccase. (A) Two molecules of (+)-catechin are 
oxidized to polycatechin by laccase. (B) Sinapic acids are oxidized by laccase into 
dimers. 
    
In a previous investigation, a laccase (CotA), which is found on the spore coat of 
Bacillus subtilis, was engineered by directed evolution for improved activity in organic 
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solvents. A CotA variant was identified with a Thr480Ala (T480A-CotA) amino acid 
substitution [44] after only one round of evolution. The screen was performed at 60 % 
DMSO and it was 2.38-fold more active than the wild-type CotA (wt-CotA) with 
substrate 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS). T480A-CotA 
was more active from a range of 0 – 70 % DMSO. In addition, the variant was more 
active in ethanol, methanol and acetonitrile. In this study, the catalysis of T480A-CotA 
and wt-CotA in the spore coat was determined with natural phenolic compounds, such as 
(+)-catechin, (-)-epicatechin and sinapic acid in aqueous-organic media.  
 
3.1 Materials 
Wt-CotA and T480A-CotA was expressed and purified on B. subtilis spores by following 
published procedures [44]. One unit is defined as a A of 0.001 per min at 37 ◦C in a 300 
l reaction volume on a 96-well microplate at absorbance 433 nm (SpectraMax_M2) 
using (+)-catechin (433 nm), or absorbance 440 nm using (-)-epicatechin, or absorbance 
at 512nm using sinapic acid. Dimethyl sulfoxide (DMSO), acetonitrile, methanol, ethanol, 
acetonitrile, (+)-catechin, (−)-epicatechin, sinapic acid were procured from Sigma- 









3.2.1 Wt-CotA and T480A-CotA Activity Versus pH 
Substrate stocks were prepared for (+)-catechin (200 mM), (−)-epicatechin (200 mM) and 
sinapic acid (200 mM) in methanol. Each stock solution was prepared fresh before use. 
The purified spore pellets of wt-CotA or T480A-CotA were resuspended in aqueous 
CuCl2 (0.25 mM) for 60 minutes. Next, spore suspension was diluted in citric phosphate 
buffer (100 mM, 0.25 mM CuCl2). 
The total volume of the reaction was 300 l. Substrate (30 l; 20 mM) was added 
to citrate phosphate buffer (250 l; 100 mM) and methanol (10% v/v) solution containing 
CuCl2 (0.25 mM). The reaction was initiated with the spore resuspension (20 l, OD580 = 
0.1 – 0.3). The pH was varied from 2 - 8 for the reactions. The absorbance 433 nm for 
(+)-catechin (433 nm), (−)-epicatechin (440 nm), or sinapic acid (512 nm) was measured 
every 5 min for 60 min at 37 ◦C. Each reaction was done in triplicate. Control 
experiments were done with spores that had the cotA gene knockout (strain1S101, 
Bacillus Genetic Stock Center, The Ohio State University, Columbus, OH, USA).  
 
3.2.2 Determination of Kinetic Parameters of Wt-CotA and T480A-CotA  
The total volume of the reaction was 300 l. Substrate (30 l; 0.05 – 6.0 mM) was added 
to citrate phosphate buffer (250 l; 100 mM; pH 7) and methanol (20% v/v) solution 
containing CuCl2 (0.25 mM). The reaction was initiated with the spore resuspension (20 
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l; OD580nm = 0.1 – 0.3). Km and Vmax was determined for wt-CotA and T480A-CotA. The 
absorbance 433 nm for (+)-catechin (433 nm), (−)-epicatechin (440 nm), or sinapic acid 
(512 nm) was measured every 5 min for 60 min at 37 ◦C. Each reaction was done in 
triplicate. Control experiments were done with spores that had the cotA gene knockout 
(strain1S101, Bacillus Genetic Stock Center, The Ohio State University, Columbus, OH, 
USA). 
 
3.2.3 Wt-CotA and T480A-CotA Activity in Organic Solvents 
The activity of wt-CotA and T480A-CotA was determined in DMSO, methanol, ethanol, 
and acetonitrile. The concentration of organic solvents used in the reaction media ranged 
from 0 – 70 % (v/v). The substrates used were (+)-catechin, (-)-epicatechin and sinapic 
acid and concentrations were 10 mM for each substrate. An OD580nm 0.1 – 0.3 was used 
for wt-CotA and T480A-CotA. Control experiments were done with spores that had the 
cotA gene knockout (strain1S101, Bacillus Genetic Stock Center, The Ohio State 
University, Columbus, OH, USA). The Vmax measurement is similar to section 3.2.2. 
 
3.2.4 Wt-CotA and T480A-CotA Recylcing in Organic Solvents 
CotA was recycled and the total product yield was determined over a 23-hour period. The 
spores were resuspended in aqueous CuCl2 (0.25 mM) solution for 60 minutes at 37 °C. 
Next, the spores were centrifuged and the supernatant was discarded. The spores were 
resuspended in citrate phosphate buffer (100 mM, pH 7) with organic solvents (60, 20, 40, 
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and 30 % (v/v) for DMSO, acetonitrile, methanol, and ethanol) at 37 °C with a final 
OD580 of 0.2. The spores were incubated for four hours and then the spores centrifuged 
and the supernatant was discarded. The reaction was initiated by resuspending the spore 
with 300 L (+)-catechin (10 mM) in citrate phosphate buffer (100 mM, pH 7) with 
organic solvents (60, 20, 40, and 30 % (v/v) for DMSO, acetonitrile, methanol, and 
ethanol) at 37 °C. The absorbance was taken at 433 nm after 60 minutes to determine the 
product yield (A433nm_product). This cycle was repeated seven times over 23-hours. 
Control experiments were done with spores that had the cotA gene knockout (strain1S101, 
Bacillus Genetic Stock Center, The Ohio State University, Columbus, OH, USA). 
 
3.3 Results and Discussion 
 
3.3.1 Wt-CotA and T480A-CotA Activity Versus pH 
The activity was measured for wt-CotA and T480A-CotA with (+)-catechin, 
(-)-epicatechin or sinapic acid under different pH (range from 2 to 8) (Figure 3.3). The 
activity trends were similar for wt-CotA and T480A-CotA towards (+)-catechin, 
(-)-epicatechin and sinapic acid. For example, wt-CotA and T480A-CotA have low 
activity at acidic pH and the activity rise to a maximum at approximately pH 7 for all the 
substrates. In addition, T480A-CotA always has greater activity than the wt-CotA. The 
amino acid substitution does not change the pH optimum for both enzymes; however, the 
T480A displays a higher Vmax [44]. A dramatic increase of laccase activity from pH 6 to 7 
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for the oxidation of (+)-catechin, (-)-epicatechin and sinapic acid was observed (Figure 
3.3A-C). At pH 7, wt-CotA activity increases 2.9, 1.8 and 2.6-fold for substrate 
(+)-catechin, (-)-epicatechin and sinapic acid in comparison to that at pH 6. For 
T480A-CotA, the activity at pH 7 increases 3.9, 2.5 and 2.3-fold for substrate 
(+)-catechin, (-)-epicatechin and sinapic acid comparing to that at pH 6. Also, the laccase 
activity dropped from pH 7 to 8. Therefore, the optimum pH values of wt-CotA and 
T480A-CotA for substrates (+)-catechin, (-)-epicatechin and sinapic acid were around pH 
7. Also, T480A-CotA shows 1.8, 4.4, 1.7-fold higher activity than wt-CotA in pH 7 for 
substrates (+)-catechin, (-)-epicatechin and sinapic acid, respectively. Therefore, 


















Figure 3.3  Effect of pH on laccase-catalyzed oxidation of (+)-catechin (A), 
(-)-epicatechin (B), and sinapic acid (C) is determined for wt-CotA (closed circles) and 







Figure 3.3 (continued)  Effect of pH on laccase-catalyzed oxidation of (+)-catechin (A), 
(-)-epicatechin (B), and sinapic acid (C) is determined for wt-CotA (closed circles) and 
T480A-CotA (open circles). 
 
3.3.2 Determination of Kinetic Parameters 
Vmax and Km was determined for wt-CotA and T480A-Cot with (+)-catechin, 
(-)-epicatechin and sinapic acid (Figure 3.4, Table 3.1). T480A-CotA has a Km smaller for 
(+)-catechin, (-)-epicatechin than the wt-CotA. Wt-CotA has a Km 1.46-fold and 1.84-fold 
greater than T480A-CotA for (+)-catechin and (-)-epicatechin, respectively. On the other 
hand, T480A-CotA has a Km larger for sinapic acid. In all cases, T480A-CotA has a 
greater Vmax [44]. The Vmax/Km for T480A-CotA was 4.1-fold, 5.6-fold, and 1.4 greater 
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Figure 3.4  Kinetic parameters of wt-CotA and T480A-CotA on Bacillus subtilis spore 
coat for substrates (+)-catechin, (-)-epicatechin and sinapic acid. (A) Kinetics of wt-CotA 
and T480A-CotA for substrate (+)-catechin. Km = 1.15 ± 0.06 mM, Vmax = 23.7 ± 0.49 
A/OD580 nm for wt-CotA; Km = 0.79 ± 0.05 mM, Vmax = 67.2 ± 1.54 A/OD580 nm for 
T480A-CotA. (B) Kinetics of wt-CotA and T480A-CotA for substrate (-)-epicatechin. Km 
= 0.94 ± 0.1 mM, Vmax = 17.6 ± 0.69 A/OD580nm for wt-CotA; Km = 0.51 ± 0.03 mM, 





Figure 3.4 (continued)  Kinetic parameters of wt-CotA and T480A-CotA on Bacillus 
subtilis spore coat for substrates (+)-catechin, (-)-epicatechin and sinapic acid. (C) 
Kinetics of wt-CotA and T480A-CotA for substrate sinapic acid. Km = 0.36 ± 0.02 mM, 
Vmax = 3.33 ± 0.04 A/OD580nm for wt-CotA; Km = 0.61 ± 0.05 mM, Vmax = 8.00 ± 0.18 
A/OD580nm for T480A-CotA. 
  
Table 3.1  Kinetics Parameters of Wt-CotA and T480A-CotA with Different Substrates 




 Vmax / Km 
(+)-catechin Wildtype 1.15±0.06 23.7±0.49 20.6 
 T480A 0.79±0.05 67.2±1.54 85 
(-)-epicatechin Wildtype 0.94±0.1 17.6±0.69 18.7 
 T480A 0.51±0.03 53.2±0.99 104.3 
Sinapic acid Wildtype 0.36±0.02 3.33±0.04 9.3 
 T480A 0.61±0.05 8.00±0.18 13.1 





3.3.3 Activity of Wt-CotA and T480A-CotA in Organic Solvent 
The activity of wt-CotA and T480A-CotA was measured at different concentrations of 
DMSO, acetonitrile, methanol and ethanol (Figure 3.4A-C, Table 3.2). In general, the 
Vmax for T480A-CotA was greater than the wt-CotA in all organic solvents. Wt-CotA and 
T480A-CotA showed slight activity over the background in buffer alone. It is clear that 
organic co-solvents are necessary to solubilize the substrate for enzymatic activity. For 
the substrates (+)-catechin and (-)-epicatechin, T480A-CotA has an optimum 
concentration of 60, 20, 40, and 30 % (v/v) for DMSO, acetonitrile, methanol, and 
ethanol (Figure 3.5A-B). For substrate (+)-catechin, T480A-CotA is 1.4 – 3.0, 1.1 – 3.0, 
1.7 – 3.4, and 1.2 – 2.4-fold more active than wt-CotA in DMSO, acetonitrile, methanol, 
and ethanol, respectively. For substrate (-)-epicatechin, T480A-CotA is 1.0 – 4.1, 1.0 – 
5.6, 1.1 – 7.9 and 1.3-6.2-fold more active in DMSO, acetonitrile, methanol, and ethanol, 
respectively. For substrate sinapic acid, T480A-CotA has an optimum concentration of 30, 
30, 30, and 20 % (v/v) for DMSO, acetonitrile, methanol, and ethanol (Figure 3.5C). 
T480A-CotA is 2.4 – 4.8, 1.4 – 2.3, 1.5 – 6.4 and 1.5 – 5.2-fold more active in DMSO, 











Figure 3.5  Vmax (A/OD580) of wt-CotA (black bars) and T480A-CotA (grey bars) in 0 






Figure 3.5 (continued)  Vmax (A/OD580) of wt-CotA (black bars) and T480A-CotA 
(grey bars) in 0 – 70 % organic solvents for substrate (+)-catechin (A), (-)-epicatechin (B), 
and sinapic acid (C). 
 
Table 3.2  Vmax (A/OD580) of Wt-CotA and T480A-CotA in 0 – 70 % Organic Solvents 






DMSO Acetonitrile Methanol Ethanol 
wt T480A wt T480A wt T480A wt T480A 
0 % 2.3±0.1 3.5±0.2 1.6±0.1 2.5±0.1 1.32±0.2 2.01±0.1 0.9±0.0 1.33±0.1 
10 % 70.4±5.3 130.9±2.3 60.5±3.3 67.6±5.3 12.4±4.0 36.6±8.4 34.9±1.4 46.0±3.4 
20 % 93.5±0.2 165.7±1.7 98.7±6.9 122±1.6 20.3±5.8 50.9±5.4 47.4±7 54.6±1.0 
30 % 75.3±13.1 150.9±8.7 86.0±2.1 92.7±2.9 48.6±5.2 84.2±3.8 33.8±1.5 66.3±1.4 
40 % 49.1±10.5 133.6±4.3 57.7±0.3 68.2±0.9 28.1±7.5 96.1±3.9 26.1±4.3 52.7±1.7 
50 % 46.3±7.1 138.3±0.8 46.6±0.1 67.0±4.2 44.0±2.7 79.6±5.2 19.2±0.4 44.9±2.2 
60 % 69.7±15.6 172.2±8.0 43.3±1.2 60.6±2.6 41.8±0.9 77.9±4.0 33.2±1.0 38.9±3.7 





Table 3.2 (continued)  Vmax (A/OD580) of Wt-CotA and T480A-CotA in 0 – 70 % 







DMSO Acetonitrile Methanol Ethanol 
wt T480A wt T480A wt T480A Wt T480A 
0 % 2.9±0.1 4.4±0.2 1.7±0.1 2.7±0.1 1.6±0.1 2.4±0.1 1.0±0.0 1.5±0.1 
10 % 9.2±0.5 22.6±6.9 16.2±1.7 42.0±3.4 19.3±0.4 56.4±9.6 11.7±1.4 22.3±3.2 
20 % 31.0±2.7 126.6±1.6 96.8±1.1 133±1.9 25.4±4.2 63.6±3.8 22.2±2.8 29.0±1.0 
30 % 57.4±5.9 154.7±2.3 74.5±3.6 77.4±1.0 43.6±3.0 90.7±3.6 44.9±1.4 76.1±1.3 
40 % 67.8±11.1 119.6±7.8 15.6±0.1 67.8±0.6 14.4±4.4 95.1±9.9 19.4±2.9 71.5±1.6 
50 % 91.2±7.8 111.0±4.3 13.4±0.1 75.3±2.8 18.7±2.6 58.2±3.4 9.6±0.4 59.9±2.1 
60 % 213.6±7.5 220.4±2.0 63.5±0.6 83.7±1.7 15.4±3.6 60.9±3.5 20.1±1.0 39.3±3.5 







DMSO Acetonitrile Methanol Ethanol 
wt T480A wt T480A wt T480A Wt T480A 
0 % 0.2±0.0 0.3±0.0 0.3±0.0 0.5±0.0 0.1±0.0 0.2±0.0 0.2±0.0 0.3±0.0 
10 % 2.5±0.4 9.6±0.2 6.2±0.6 12.3±1.0 3.3±0.4 9.6±1.0 4.4±0.0 15.6±0.9 
20 % 5.1±0.0 12.3±0.1 9.3±1.3 14.2±0.3 3.1±0.6 10.8±0.6 7.1±0.4 17.0±0.2 
30 % 5.1±1.0 13.5±0.7 13.0±0.4 23.9±0.6 1.8±0.6 11.1±0.4 3.0±0.4 15.3±0.4 
40 % 3.2±0.8 8.9±0.3 12.1±0.0 22.4±0.2 1.7±0.8 7.9±0.4 3.4±0.6 12.6±0.4 
50 % 1.8±0.5 8.7±0.0 8.7±0.0 19.7±0.8 0.4±0.3 0.6±0.1 2.8±0.1 6.7±0.6 
60 % 1.4±1.2 4.1±0.6 5.1±0.2 7.2±0.5 0.2±0.1 0.4±0.2 1.0±0.3 2.7±0.9 
70 % 1.0±0.4 3.4±0.3 0.7±0.3 1.2±0.7 0.1±0.1 0.2±0.1 0.3±0.3 0.5±0.0 
 
3.3.4 Wt-CotA and T480A-CotA Recycling in Organic Solvents 
Enzyme recycling improves overall product by reusing the catalysts for several batches. 
This reduces the cost associate with product yield. Typically, the enzyme is expressed 
purified and attached to an inert particle. This is avoided in spore display because the 
enzyme is attached to the inert surface of the spore coat. CotA recycling was investigated 
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and the total product yield was determined for (+)-catechin over 23-hour period (Figure 
3.6, Table 3.3). These percentages (v/v) were chosen at the maximum rates for the 
organic solvents, which were 60, 20, 40, and 30 % (v/v) for DMSO, acetonitrile, 
methanol and ethanol, respectively. The trend of total product is similar for wt-CotA and 
T480A-CotA. The total product yield diminishes after recycling. The product yield 
retains 60, 30, and 10 % from t = 0 to 23 hours in DMSO, acetonitrile, and ethanol, 
respectively (Figure 3.5). In methanol, wt-CotA and T480A-CotA also has lowered 
product over time, which is 10 and 30 %, respectively. The total product yields from 
T480A-CotA were 11.2, 7.1, 3.9 and 4.2 A433nm_product in DMSO, acetonitrile, methanol 
and ethanol, respectively. The optimum solvent was DMSO for the mutant. Next, the total 
product yields from wt-CotA were 3.6, 4.7, 1.4, and 2.4 A433nm_product in DMSO, 
acetonitrile, methanol, and ethanol, respectively. Wt-CotA catalyzes the most products in 
acetonitrile. In general, the biocatalysts have a greater yield in polar aprotic solvents. In 




Figure 3.6  The (+)-catechin products yields for wt-CotA (black bars), and T480A-CotA 




Table 3.3  The (+)-catechin Products Yields for Wt-CotA and T480A-CotA Were 
Determined for 7 cycles Over A 23 h Period. 
Time 
(hours) 
Product yields (A433nm_product) 
DMSO Acetonitrile Methanol Ethanol 
wt T480A wt T480A wt T480A wt T480A 
0 0.59 2.01 1.02 1.49 0.37 0.89 0.57 1.12 
4 0.58 1.95 0.96 1.42 0.31 0.88 0.5 1.05 
8 0.57 1.79 0.87 1.25 0.26 0.76 0.43 0.87 
12 0.53 1.53 0.64 0.98 0.20 0.55 0.35 0.6 
16 0.51 1.36 0.51 0.81 0.14 0.44 0.28 0.43 
20 0.49 1.35 0.39 0.64 0.09 0.32 0.21 0.25 





The kinetic parameters and the relative activity were determined with wt-CotA and 
T480A-CotA on B. subtilis spore coat for substrate (+)-catechin, (-)-epicatechin and 
sinapic acid in organic solvents. In general, the catalytic efficiency (Vmax/Km 
(A/OD580)/mM) of T480A-CotA is higher than wt-CotA for all the substrates. Then, the 
Vmax for T480A-CotA was greater than the wt-CotA in all organic solvents used in this 
study. The Vmax for T480A-CotA was up to 3.4-fold, 7.9-fold and 6.4-fold greater than 
wt-CotA for substrate (+)-catechin, (-)-epicatechin and sinapic acid, respectively. In 
addition, the catalyst can be easily removed from the reaction solution and reused. This 
allows for simpler recovery of the product from the enzyme. This investigation indicates 














ENZYME DISPLAY FOR ALKANE OXIDATION 
 
Cytochrome P450 monooxygenases (CYPs) belong to a superfamily of enzymes that 
contains heme as a cofactor. They are also known as hemoproteins. CYP enzymes have 
been widely found in animals, plants, and microorganisms. The most common reaction 
catalyzed by cytochromes P450 is a monooxygenase reaction. For example, one atom of 
oxygen is inserted into the aliphatic position of an organic substrate (RH) while the other 
oxygen atom is reduced to water (Equation A.1). Furthermore, P450s also catalyze a 
variety of reactions (Figure A.1). 
RH + O2 + NADPH + H
+ ROH + H2O + NADP
+
   Equation A.1 
 
Figure A.1  Additional P450 reactions. 
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In humans, CYPs are primarily membrane-associated proteins located either in 
the inner membrane of mitochondria or in the endoplasmic reticulum of cells. They 
metabolize thousands of endogenous and exogenous chemical [106,107]. CYPs are the 
major enzymes involved in drug metabolism, accounting for about 75% of the total 
metabolism [108]. Most drugs undergo deactivation by CYPs, either directly or by 
facilitated excretion from the body [108]. In biotechnology, their unique catalytic 
properties are attractive because they could catalyze difficult chemical reactions, as they 
even act on non-activated carbon–hydrogen bonds. Recent progress towards realizing the 
potential of using P450s towards difficult oxidations have included [109,110]:  
(1) eliminating the need for natural co-factors by replacing them with inexpensive 
peroxide containing molecules, (2) exploring the compatibility of p450s with organic 
solvents, and (3) the use of small, non-chiral auxiliaries to predictably direct P450 
oxidation. P450 systems can be used in a variety of applications (Figure A.2) 
 
Figure A.2  Function and potential applications of Cytochrome P450 systems. 
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Spore display will be used to synthesize carboxylic acids from alkanes (Figure 
A.3; see Chapter 1 for background of spore display). The first step is oxidizing the alkane 
to an alcohol by a cytochrome P450. Then, the alcohol will be converted to the aldehyde 
by an alcohol dehydrogenase. Finally, the aldehyde will be transformed to the acid by an 
aldehyde dehydrogenase. The final target is to enzymatically synthesize adipic acid (1, 
6-hexandioic acid). Adipic acid is widely used in industry. About 60% of the 2.5 billion 
kg of adipic acid produced annually is used as monomer for the production of nylon 
(textiles, carpets, and tire chords), polyurethanes, and plasticizers [111,112]. In medicine, 
adipic acid has been incorporated into controlled-release formulation matrix tablets to 
obtain pH-independent release for both weakly basic and weakly acidic drugs [113]. The 
synthesis of adipic acid is energy intensive, uses toxic, heavy metals, and nitric acid. The 
goal is to enzymatically synthesize hexanoic acid from hexane. A P450 will oxidize 
hexane to hexanol. Next, alcohol dehydrogenase will oxidize the alcohol to aldehyde.  
Finally, aldehyde dehydrogenase will oxidize the aldehyde to the acid. 
 
Figure A.3  Enzymatic synthesis of carboxylic acids from alkanes. (A) Cytochrome 
P450 catalysis of alkane to alcohol. (B) Alcohol dehydrogenase catalysis of alcohol to 
aldehyde. (C) Aldehyde dehydrogenase catalysis of aldehyde to carboxylic acid. 
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The Cytochrome P450 that will be used is CYP102A3. It is found in the Bacillus 
subtilis and has 76% similarity to the cytochrome P450 BM-3 from B. megaterium 
(CYP102A1). The structure has not been solved for CYP102A3, but it is known for CYP 
102A1 (Figure A.4). Cytochrome P450 CYP102A3 is a fusion protein that consists of a 
heme and a FAD/FMN-reductase domain. 
 
Figure A.4  Structure of CYP102A1 heme domain (PDB 2IJ2). The heme is shown as 
CPK spheres. 
 
These enzymes typically oxidize fatty acids at the and and not the 
terminal position. Wild-type CYP102A3 is most active with myristic acid 
(1-tetradecanoic acids). However, CYP102A3 S189Q/A330V mutant was found to 
oxidize octane at the terminal position and the specificity was 42%. In this study, we 
integrated CYP102A3 S189Q/A330V (P450) gene, fused with a green fluorescence 
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protein (GFP) as signaling label into the genome of B. subtilis. The first step is to display 
CYP102A3 on the spore coat. 
 
Materials 
All chemicals were of analytical reagent grade or higher quality and were purchased from 
Sigma-Aldrich (St. Louis, MO). Enzymes were purchased from Invitrogen (Carlsbad, CA) 
and New England Biolabs (Ipswich, MA). Primers were procured from Invitrogen 
(Carlsbad, CA). Plasmid pDG364_CotB_ HuPTH1r_GFP was previously constructed in 
our lab. CYP102A3 S189Q/A330V mutant was constructed and modified for Bacillus 
subtilis expression and inserted into plasmid pJ241 to construct pJ241_P450 by DNA2.0 




Gibson Assembly was developed by Dr. Daniel Gibson and his colleagues at the J. Craig 
Venter Institute and licensed to NEB by Synthetic Genomics, Inc. This method efficiently 
joins multiple overlapping DNA fragments in a single-tube isothermal reaction. 
Oligonucleotides, DNA with varied overlaps (15–80 bp) and fragments hundreds of 
kilobases long have been successfully assembled by using Gibson Assembly. The 




Figure A.5  Overview of the Gibson Assembly Cloning Method. 
 
In Gibson Assembly, DNA fragments that need to be assembled are first amplified 
by PCR. Overalp was added by using overlapping primers. Next, these DNA fragments 
are mixed with a cocktail of three enzymes, along with other buffer components. The 
three required enzyme activities are: exonuclease, DNA polymerase, and DNA ligase. 
The exonuclease chews back DNA from the 5' end. The resulting single-stranded regions 
on adjacent DNA fragments can anneal. The DNA polymerase extends 3’ ends to fill in 
any gaps along the gene. The DNA ligase covalently joins the DNA of adjacent segments, 




Plasmid pDG364_CotB_P450_GFP was constructed from 
pDG364_CotB_HuPTH1r_GFP. First, pDG364_CotB_ HuPTH1r_GFP were digested 
with PmeI and BamH1 to create the vector. P450 gene was amplified from pJ241_P450. 
GFP was amplified from pDG364_CotB_ HuPTH1r_GFP. The overlapping primers for 
amplification are shown in Table A.1. Then, DNA fragments P450 and GFP were inserted 
into the vector by using Gibson Assembly (Figure A.6). The constructed plasmid was 
transformed into E.coli DH5 and plated on LB plates containing ampicillin (50 g/mL). 
Four colonies were randomly picked and the plasmids were isolated for DNA sequencing. 
The correct plasmid was integrated into the amyE locus into B. subtilis strain PY79 (Ohio 
State University, Bacillus Genetic Stock Center, Columbus Ohio).  
The insert includes CotB as carrier protein then is followed by a linker 
(-GlyPheLysLeu Gly4Ser-) that connects CYP102A3 S189Q/A330V. The P450 has a 




Figure A.6  Overview of the Gibson Assembly cloning method. 
 
Table A.1  Overlapping Primers Used in DNA Construction for Plasmid 
pDG364_CotB_P450_GFP. 







Four colonies were randomly collected after the transformation of Gilbson Assembly 
assembled plasmid into E.coli DH5a. The plasmids were insolated and double digested 
with PmeI and BamH1. The gel picture showed that one plasmid (at lane 4) has a 
~4000bp DNA fragment after double digestion, indicating the success of Gilbson 
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Assembly (Figure A.7). The sequence of this DNA fragment was investigated by using 
six primers (Figure A.8, Figure A.9). Next, the chromosome DNA was isolated from 
transformed B. subtilis and P450 region was amplified with P450-forward and 
P450-reverse. The sequence of the resulting PCR product was investigated. The 
sequencing data indicates the successful construction of pDG364_CotB_P450_GFP and 
successful integration into B.subtilis. 
 
Figure A.7  Agarose gel of isolated plasmids after PmeI and BamH1 double restrction digestion. 












Figure A.8  Sequence of CotB_P450_GFP was acquired by SnapGene (GSL Biotech 

























































Figure A.9  Full sequence result of CotB_P450_GFP for P450. The sequence is 











SEQUENCE DATA OF COTA VARIANTS 
 






























Figure B.1  Full sequence results of Y19-CotA. The sequence is analyzed by ApE-A 






Figure B.2  Sequence results of E498G-CotA near the subtitution site. The mutated sites 







Figure B.3  Sequence results of L343S-CotA near the subtitution site. The mutated sites 
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